The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma-Reference-Cited by-同舟云学术

The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma

Published:2000-12 Issue:3 Volume:57 Page:273-278
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Blasko John C.,Grimm Peter D.,Sylsvester John E.,Cavanagh William

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference13 articles.

1. Prostate,1992

2. Should brachytherapy be considered a therapeutic option in localized prostate cancer?;Blasko;Urol Clin North Am,1996

3. Transperineal percutaneous iodine-125 implantation for prostatic carcinoma using transrectal ultrasound and template guidance;Blasko;Endocuriether Hypertherm Oncol,1987

4. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer;Catalona;J Urol,1994

5. Pd-103 brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma;Dattoli;Int J Radiat Oncol Biol Phys,1996

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiotherapy-Related Gene Signature in Prostate Cancer;Cancers;2022-10-14

2. Comparative effectiveness of low-dose-rate brachytherapy with or without external beam radiotherapy in favorable and unfavorable intermediate-risk prostate cancer;Scientific Reports;2022-06-30

3. Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancer;Brachytherapy;2022-05

4. Reduction of toxicity in brachytherapy using a new technique;Brachytherapy;2021-07

5. Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer;International Journal of Radiation Oncology*Biology*Physics;2021-04